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Abstract
Pancreatic duct glands (PDGs) are tubule-alveolar glands associated with the pancreatic duct system and can be
considered the anatomical counterpart of peribiliary glands (PBGs) found within the biliary tree. Recently, we
demonstrated that endodermal precursor niches exist fetally and postnatally and are composed functionally of
stem cells and progenitors within PBGs and of committed progenitors within PDGs. Here we have characterized
more extensively the anatomy of human PDGs as novel niches containing cells with multiple phenotypes of
committed progenitors. Human pancreata (n = 15) were obtained from cadaveric adult donors. Specimens were
processed for histology, immunohistochemistry and immunofluorescence. PDGs were found in the walls of
larger pancreatic ducts (diameters > 300 lm) and constituted nearly 4% of the duct wall area. All of the cells
identified were negative for nuclear expression of Oct4, a pluripotency gene, and so are presumably committed
progenitors and not stem cells. In the main pancreatic duct and in large interlobular ducts, Sox9+ cells
represented 5–30% of the cells within PDGs and were located primarily at the bottom of PDGs, whereas rare
and scattered Sox9+ cells were present within the surface epithelium. The expression of PCNA, a marker of cell
proliferation, paralleled the distribution of Sox9 expression. Sox9+ PDG cells proved to be Pdx1+/Ngn3+/–/
Oct4A. Nearly 10% of PDG cells were positive for insulin or glucagon. Intercalated ducts contained Sox9+/
Pdx1+/Ngn3+ cells, a phenotype that is presumptive of committed endocrine progenitors. Some intercalated
ducts appeared in continuity with clusters of insulin-positive cells organized in small pancreatic islet-like
structures. In summary, PDGs represent niches of a population of Sox9+ cells exhibiting a pattern of phenotypic
traits implicating a radial axis of maturation from the bottoms of the PDGs to the surface of pancreatic ducts.
Our results complete the anatomical background that links biliary and pancreatic tracts and could have
important implications for the common patho-physiology of biliary tract and pancreas.
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Introduction
The pancreatic duct system is an intricate network com-
posed of intercalated, intralobular, interlobular and main
pancreatic ducts (Udager et al. 2010; Reichert & Rustgi,
2011; Burke & Tosh, 2012). Intercalated ducts are lined by
squamous-like epithelial cells and, at the terminal end, by
centro-acinar cells interfaced with pancreatic acini. Intralob-
ular and interlobular ducts are lined with cuboidal epithe-
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lial cells. Finally, the main pancreatic duct is lined with sim-
ple columnar epithelial cells (Reichert & Rustgi, 2011). The
main pancreatic duct merges with the common bile duct,
forming the hepato-pancreatic common duct opening into
the duodenum at the level of the major papilla (Udager
et al. 2010; Reichert & Rustgi, 2011; Burke & Tosh, 2012;
Cardinale et al. 2012a; Wang et al. 2013).
Liver, biliary tree and pancreas share a common embry-
ological origin (Wandzioch & Zaret, 2009; Udager et al.
2010; Burke & Tosh, 2012; Cardinale et al. 2012a). The
embryological development of liver and pancreas in mam-
mals is associated with the appearance of a common endo-
dermal stem/progenitor within the primitive duodenum
(Zhou et al. 2007; Wandzioch & Zaret, 2009). This bilio-pan-
creatic progenitor differentiates in distinct lineages driven
by specific transcription factors such as Hes1 in the case of
the hepato-biliary fate, or Pdx1/Ngn3/MafA in the case of
the pancreatic fate (Reichert & Rustgi, 2011; Kawaguchi,
2013). In particular, Pdx1 is required for specification of all
pancreatic lineages, and the expression of Ngn3, MafA,
NeuroD, Hnf6, and Pax4 is necessary for endocrine lineage
commitment (Reichert & Rustgi, 2011; Kawaguchi, 2013).
Recently, it has been shown that bilio-pancreatic stem/
progenitors reside within peribiliary glands (PBGs) in the
human biliary tree in fetal and adult tissues (Cardinale et al.
2011; Carpino et al. 2012; Wang et al. 2013). Both intrahep-
atic and extrahepatic bile ducts contain PBGs within their
walls (Cardinale et al. 2011; Carpino et al. 2012; Wang et al.
2013). PBGs contain multiple lineage stages of determined
stem/progenitor cell subpopulations [human biliary tree
stem/progenitor cells (hBTSCs)] expressing classic endoder-
mal stem cell markers (e.g. Sox2, Nanog, Oct4, Sox9, Sox17,
Pdx1) (Cardinale et al. 2011; Carpino et al. 2012, 2014;
Semeraro et al. 2012; Wang et al. 2013). Once isolated by
immunoselection or culture selection, hBTSCs are able
under serum-free, defined conditions to self-replicate for
months and then are able to be lineage-restricted under
distinct defined conditions into hepatocytes, cholangiocytes
or pancreatic islets (Cardinale et al. 2011; Carpino et al.
2012; Wang et al. 2013). Moreover, these hBTSCs were able
to correct cirrhosis if injected into the livers of immunocom-
promised murine hosts (Cardinale et al. 2011; Carpino et al.
2012, 2014; Semeraro et al. 2012) or to correct experimen-
tally induced diabetes if injected into the fat pads of
immunocompromised mice treated with streptozotocin
(Wang et al. 2013).
Human pancreatic duct glands (PDGs) are glands associ-
ated with pancreatic ducts (Strobel et al. 2010); these struc-
tures seem to represent the anatomical counterpart of PBGs
found within the biliary tree (Nakanuma, 2010). However,
the precursor populations isolated from the fetal or adult
human pancreata proved to contain only committed pro-
genitors, as indicated by their inability to self-replicate
ex vivo and by the absence of expression of pluripotency
genes (OCT4, SOX2, NANOG, etc.) and other markers typical
of stem cells (Wang et al. 2013). By contrast, those in the
fetal and adult biliary tree included both stem cells and
committed progenitors (Wang et al. 2013). This interpreta-
tion corroborates the findings of others that there are no
stem cells, only committed progenitors, in the pancreas
postnatally (Zhou et al. 2007; Seifert & Xiong, 2014).
The aims of the present manuscript have been as follows:
(1) to study the anatomical distribution of PDGs along the
full length of the human pancreatic duct system, (2) to
investigate the expression of endodermal progenitor cell
and proliferation markers within PDGs, and (3) to describe
the spatial distribution of cells expressing endodermal pro-
genitor markers within PDGs and the anatomical organiza-
tion of PDGs as novel progenitor cell niches.
Materials and methods
Human pancreata (n = 15) were obtained from cadaveric donors.
All tissues were obtained from the surgical department of Sapienza
University of Rome, Italy. Informed consent was obtained from next
of kin for use of the tissues for research purposes, the study proto-
cols received Institutional Review Board approval, and processing
was compliant with Good Manufacturing Practice. All of the sam-
ples were derived from adults, aged 19–73 years, with a median
age of 48 (SD 11.89).
Organ donors were routinely screened for underlying patholo-
gies; all specimens included in the present study came from donors
without liver (steatosis, viral hepatitis, cirrhosis) or pancreatic (dia-
betes, pancreatitis) diseases as demonstrated by clinical and serolog-
ical parameters obtained during transplantation procedures. In
accordance, the histological examination of specimens did not show
any signs of damage such as inflammation or necrosis.
Pancreas and duodenum were obtained en bloc from organ
transplantation procedures. The duodenal wall was sectioned, and
the major papilla was separated. The head of the pancreas was dis-
sected, and the main pancreatic duct, the common bile duct (chole-
docus) and the hepato-pancreatic common duct were visualized.
For each case, samples were taken (1) at the level of the hepato-
pancreatic ampulla, (2) at the level of the main pancreatic duct
prior to merging with the choledocus, and (3) at the different levels
of the pancreatic body and tail.
Light microscopy (LM), immunohistochemistry (IHC)
and immunofluorescence (IF)
Specimens were fixed in 10% buffered formalin for 2–4 h, embed-
ded in low-temperature-fusion paraffin (55–57 °C), and 3- to 4-lm
sections were stained with haematoxylin-eosin and Alcian-PAS.
For IHC, sections were mounted on glass slides coated with 0.1%
poly-L-lysine. Sections were hydrated in graded alcohol and rinsed
in phosphate-buffered saline (PBS, pH 7.4). Endogenous peroxidase
activity was blocked by a 30-min incubation in methanolic hydro-
gen peroxide (2.5%). The endogenous biotin was then blocked by
the Biotin Blocking System (code X0590; Dako, Glostrup, Denmark)
according to the instructions supplied by the vendor. Antigens were
retrieved by applying Proteinase K as suggested by the vendor
(code S3020; Dako) for 10 min at room temperature. Sections were
then incubated overnight at 4 °C with primary antibodies. A com-
plete list of primary antibodies, sources and dilutions is given in
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Table 1. Samples were rinsed twice with PBS for 5 min, and incu-
bated for 20 min at room temperature with secondary biotinylated
antibody and then Streptavidin-HRP (both LSAB+ System-HRP, code
K0690; Dako). Diaminobenzidine (Dako) was used as substrate, and
sections were counterstained with haematoxylin.
For IF, non-specific protein binding was blocked by 5% normal
goat serum. Sections were incubated with primary antibodies at
room temperature for 1 h. All primary antibodies were diluted in
1% bovine serum albumin in PBS-Tween 20 (PBS-T). The sections
were then washed twice with PBS-T and incubated for 1 h with
labelled isotype-specific secondary antibodies (dilution 1 : 50): anti-
mouse Alexa Fluor-488, -546, anti-rabbit Alexa Fluor-488, -546, anti-
goat Alexa Fluor -488, -546, and anti-guinea pig -488 (Alexa Fluor;
Invitrogen Ltd, Paisley, UK). They were counterstained with 40,6-dia-
midino-2-phenylindole for visualization of cell nuclei. For all
immunoreactions, negative controls consisted of the primary anti-
body being replaced with pre-immune serum.
To perform double IF with two rabbit primary antibodies, we fol-
lowed a three-step protocol (Nobili et al. 2012): sections were incu-
bated with anti-PDX1 (or anti-NGN3); then, an anti-rabbit
secondary fluorescent antibody (AlexaFluor-488) was applied;
finally, the antibody for Sox9 was pre-labelled with a fluorophore
using the APEX-594 labelling kit (Invitrogen, catalogue #A10474)
and was applied to the section. All antibodies were diluted (1 : 50)
and incubated at room temperature (RT) for 1 h. Adequate controls
were performed (supplementary figures 1–3).
Sections were examined in a coded fashion using the Leica
Microsystems DM 4500 B Light and Fluorescence Microscopy (Wet-
zlar, Germany) equipped with a Jenoptik Prog Res C10 Plus Video-
cam (Jena, Germany). LM, IHC and IF observations were processed
with an Image Analysis System (IAS; Delta Sistemi, Rome, Italy) and
were performed independently by two researchers in a blind fash-
ion (Nobili et al. 2014).
Haematoxylin-eosin (H&E) stained slides and IHC stained slides
were scanned with a digital scanner (Aperio Scanscope CS System;
Aperio Technologies, Inc., Oxford, UK) and processed by ImageS-
cope. For morphometric analysis, the measurement of the duct
diameter included the ductal wall; the surface occupied by PDGs
was measured as the area occupied by glandular acini (lm2); and
the area fraction with respect to the total area of examined duct
wall was also calculated and expressed as a percentage, as done
previously (Carpino et al. 2014).
For each organ, three different sections of the main pancreatic
duct were separately evaluated at the level of the pancreatic head
and of the tail; similarly, up to five interlobular pancreatic ducts
were evaluated for each organ; the mean was obtained for each
organ and, finally, the data were displayed as mean  SD of values
coming from the 15 organs.
An image analysis algorithm was used to quantify the percentage
of cells with Sox9 nuclear expression within PDGs. The number of
Sox9+ cells was calculated as the percentage of cells with positive
nuclei with respect to the total number of cells within PDGs. Counts
were performed in all glandular acini in examined ducts.
The number of positive cells for other markers was counted in a
random, blinded fashion in six non-overlapping fields (magnifica-
tion 209) for each slide. The data are expressed as the percentage
of positive cells. Data are summarized by a semi-quantitative score,
as done previously:  < 1%; +⁄ = 1–5%; + = 5–30%; ++ = 30–50%;
+++ > 50% (Glaser et al. 2009; Carpino et al. 2012).
Pancreatic ducts were sub-divided into main pancreatic duct,
interlobular ducts, intralobular ducts and intercalated ducts accord-
ing to their anatomical features (Reichert & Rustgi, 2011). For each
specimen, at least three different sections of the main pancreatic
duct were examined at different levels. At least five different inter-
lobular ducts, intralobular ducts, or intercalated ducts were exam-
ined for each specimen.
Many of the markers studied are known to be associated with
both stem cells and progenitors; one of the ones expressed by stem
cells but not by committed progenitors is nuclear expression of
Oct4A, a pluripotency gene (Zhou et al. 2007; Wang et al. 2013; Sei-
fert & Xiong, 2014). Therefore, nuclear, not cytoplasmic, expression
of Oct4A was evaluated to identify true stem cells.
Nuclear expression of specific transcription factors, in combina-
tion with the findings from our prior studies (Cardinale et al. 2011;
Carpino et al. 2012; Wang et al. 2013) and those of others (Zhou
et al. 2007; Liu et al. 2014; Seifert & Xiong, 2014) has been inter-
preted as follows: Oct4A expression recognizes only cells with stem
cell phenotype; Sox9, Pdx1, and Lgr5 expression recognize cells with
both stem and progenitor cell phenotype; cells with Oct4A/Sox9+/
Pdx1+/Ngn3 phenotype are considered pancreatic committed pro-
genitor cells for both acinar and endocrine fates; Cells with an
Oct4A/Sox9+/Pdx1+/Ngn3+ phenotype are considered pancreatic
endocrine progenitor cells.
Statistical analysis
Data were expressed as mean  SEM. Statistical analyses were per-
formed by SPSS statistical software (SPSS Inc., Chicago, IL, USA). Dif-
ferences between groups for not normally distributed parameters
Table 1 List of antibodies used.
Name Host/isotype Source Catalogue# Dilution
CK7 (cytokeratin7) Mouse IgG1 Dako M7018 1 : 100
Pan-CK Mouse IgG1 Dako M7010 1 : 50
Oct4A Rabbit IgG Cell Signaling #2050 1 : 50
Lgr5 Goat IgG Santa Cruz SC-68580 1 : 50
PCNA Mouse IgG2a Dako M0879 1 : 100
Pdx1 Rabbit IgG Santa Cruz SC-25403 1 : 50
Sox9 Rabbit IgG Millipore AB5809 1 : 100
Ngn3 Rabbit IgG Abcam Ab38548 1 : 50
Rabbit IgG Millipore AB5684 1 : 200
Glucagon Rabbit IgG Santa Cruz SC-13091 1 : 50
Insulin Guinea pig IgG Dako IS002 1 : 100
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were tested by Mann–Whitney U-tests. Statistical significance was
set to a P-value < 0.05.
Results
Pancreatic duct gland distribution along human
pancreatic duct system
The presence of glandular elements (PDGs) was investigated
along the human pancreatic duct system. In accordance
with their anatomical division and position, the main pan-
creatic, interlobular, intralobular and intercalated ducts
were studied separately.
The head and the tail of the main pancreatic duct at the
head was evaluated. Progressing from the head towards
the pancreatic tail, the diameter of the main pancreatic
duct decreased progressively from  2000 to  650 lm.
The main pancreatic duct displayed glandular elements
located within its wall and called PDGs. PDGs occupied an
average area of 50 877  50 121 lm2 (Fig. 1). The large
variability observed in the areas of the PDGs simply repre-
sents the progressive reduction of duct diameter from the
pancreatic head to the tail. Therefore, data from main pan-
creatic duct at the head and at the tail have been consid-
ered separately.
Pancreatic duct glands occupied an average area of
104 581  14 092 lm2 at the pancreatic head and an aver-
age area of 45 166  6663 lm2 at the pancreatic tail
(P < 0.05); therefore, the PDG area is strictly correlated with
the duct diameter (r = 0.69; P < 0.01).
Moreover, the percentage of the duct area (area fraction)
occupied by PDGs was 4.11  1.60% (pancreatic head) and
4.38  2.63% (pancreatic tail). The PDG area fraction did
not correlate with the duct diameter, and no differences
Fig. 1 Distribution of pancreatic duct glands (PDGs) within pancreatic ducts. (A) Haematoxylin-eosin stains of main pancreatic duct. The main pan-
creatic duct displays glandular elements called PDGs that are located within its wall. The PDG area is strictly correlated with the duct diameter.
Near the hepato-pancreatic ampulla, the main pancreatic duct displays two types of glands: intramural (yellow arrows) and extramural (red arrow)
PDGs. Distal to the hepato-pancreatic ampulla, only intramural PDGs could be recognized. The area in the boxes is magnified in the lower images.
D, duodenum (wall: sub-mucosal layer). (B) Haematoxylin-eosin stain of pancreas. At the level of interlobular pancreatic ducts, PDGs (yellow
arrows) are present only in larger ducts (diameter > 300 lm: left images). Smaller interlobular ducts (diameter < 300 lm: right images) do not
contain PDGs. Areas in the boxes are magnified in the lower images.
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were found when the fraction of the area in the head of
the pancreas was compared with that in the pancreatic tail.
In the head of the pancreas, but not in the tail, the main
pancreatic duct displayed two types of glands: intramural
and extramural PDGs. The intramural PDGs were found
within the duct wall and appeared as internalized pouches
of the surface epithelium, whereas extramural PDGs were
located outside and were tethered to the wall of the ducts
(Fig. 1A).
The presence of PDGs was investigated at the level of the
interlobular pancreatic ducts (IL-PDs). PDGs were present
only in larger IL-PDs (diameter > 300 lm). Smaller IL-PDs (di-
ameter < 300 lm) did not have PDGs (Fig. 1B).
Larger IL-PDs had an average diameter = 383.3 
22.6 lm; PDGs occupied an average area of 5074 
368 lm2 of the IL-PD wall. This area was lower in compar-
ison with the main pancreatic duct (P < 0.01). Moreover,
the percentage of the duct area (area fraction) occupied by
PDGs was 3.80  2.21%, and was not different in compar-
ison with the main pancreatic duct. Data are summarized in
Table 2.
Phenotypic traits cells in pancreatic duct glands
PDGs were partly composed of mucinous acini, which repre-
sented 5–30% (semi-quantitative score = +) of glandular
cells as demonstrated by both Alcian and PAS positivity
(Fig. 2). Mucin-producing cells were more numerous in
PDGs associated with the main pancreatic duct than in
those associated with interlobular ducts.
The expression of markers representative of endodermal
stem and progenitor cells (Oct4A, Sox9, Pdx1, Lgr5, Ngn3)
was investigated within PDGs. All PDG cells were negative
for Oct4a (data not shown). In the main pancreatic duct
and large IL-PDs, [Oct4A/Sox9+] cells were found within
PDGs. In PDGs, these cells represented a sub-population
Table 2 Pancreatic duct gland (PDG) distribution.
Diameter (lm) PDG area (lm2) PDG volume (%)
Main pancreatic duct (at pancreatic head) 1976.8  183.5* 104 581  14 092* 4.11  1.60
Main pancreatic duct (at pancreatic tail) 1213.4  336.7* 45 166  6663* 4.38  2.63
Large interlobular pancreatic duct 383.3  22.6* 5074  368* 3.80  2.21
Small interlobular pancreatic duct 198.3  61.6* – –
Data are expressed as means  SD.
*P < 0.01 vs. other groups.
A B Ba
C Ca Cb
Fig. 2 Pancreatic duct glands (PDGs) contain mucin-producing cells. Alcian-PAS (periodic acid Schiff) stain of duodenum (A), main pancreatic duct
(B) and interlobular pancreatic ducts (C). (A) In the duodenum, Brunner’s glands are PAS-positive (magenta cells: red arrows), whereas goblet cells
in intestinal glands are Alcian-positive (purple cells: blue arrows). (B,C) PDGs in main and interlobular pancreatic ducts are PAS+ (red arrows) or
Alcian+ (blue arrows). Area in the box in B is magnified in Ba. Areas in the boxes in C are magnified in Ca and Cb.
© 2015 Anatomical Society
Progenitors in pancreatic duct glands, G. Carpino et al.478
ranging from 5 to 30% of glandular cells (semi-quantitative
score = +) with a mean of 19.5  8.3% (Fig. 3A). No differ-
ences were found in the findings from the head vs. the tail
of the pancreas. In the main pancreatic duct, Sox9+ cells
were located primarily at the bottom of PDGs, whereas rare
(less than 5%) and scattered Sox9+ cells were present within
the surface epithelium. In the smaller IL-PDs, which lack
PDGs, [Oct4A/Sox9+] cells (semi-quantitative score = ++)
were found within the surface epithelium (Fig. 3B).
The expression of PCNA, a marker of cell proliferation,
paralleled the distribution of Sox9 (Fig. 3C). PCNA+ cells
constituted 17.2  6.5% of cells within PDGs and were not
found outside the PDGs. The number of PCNA+ cells
decreased progressively in the transitioning to the surface
epithelium. At the surface, PCNA+ cells were rare (< 5%).
The percentage of PDG cells positive for Pdx1 [Oct4A/
Sox9+] was 5–30% (semi-quantitative score = +; Fig. 4A).
Pdx1 positivity essentially co-localized with Sox9-positivity
(Fig. 4B). No differences in Oct4A/Sox9+/Pdx1+ cell num-
bers were found in PDGs associated with the main pancre-
atic duct in the head of the pancreas, with the main
pancreatic duct in the pancreatic tail, and in the larger
interlobular ducts.
Ngn3+ cells were rare in PDGs associated with the main
pancreatic duct (semi-quantitative score = +/; Fig. 4C, left
image), but their percentage increased in PDGs associated
with larger interlobular ducts (semi-quantitative score = +;
Fig. 4C, right image).
Only a few Lgr5+ cells (semi-quantitative score = +/)
were present in PDGs. Lgr5 expression occurred in Sox9+
Fig. 3 Sox9+ cells and proliferating cells are located within pancreatic duct glands (PDGs). (A) Immunohistochemistry for Sox9 in human pancreatic
ducts. In the main pancreatic and large interlobular pancreatic ducts, Sox9+ cells (arrows) were evident within PDGs. In PDGs, Sox9+ cells comprise
sub-populations ranging from 5 to 30% of glandular cells. In the main and larger interlobular pancreatic ducts, Sox9+ cells were mostly located at
the bottom of PDGs (arrows), while rare and scattered Sox9+ cells were present within the surface epithelium (arrowheads). In smaller interlobular
pancreatic ducts, Sox9+ cells were found within the surface epithelium (arrows). (B) Double immunofluorescence for CK7 (green) and Sox9 (red).
Nuclei are counterstained in blue. Sox9+ cells were present in the small interlobular duct (arrows) and intercalated ducts (arrowheads). A few
Sox9+ cells were present in intralobular ducts (lower images, arrow). (C) Immunohistochemistry for PCNA in human pancreatic ducts. The expres-
sion of PCNA, a marker of cell proliferation, followed the distribution of Sox9. PCNA+ cells (arrows) were located mostly in PDGs (higher magnifi-
cation in a). The number of PCNA+ cells progressively decreased with transitions towards the surface epithelium. At the surface (higher
magnification in b), epithelial cells were essentially negative for PCNA (arrowheads).
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cells but not in insulin+ ones (Fig. 4D) or glucagon+ ones
(data not shown) within PDGs.
The expression of insulin and glucagon was investigated
within PDGs. Interestingly, 7.6  2.4% of PDG cells were
positive for insulin (Fig. 5A,B) or glucagon (Fig. 5C,D). Insu-
lin+ (or glucagon+) cells were more numerous in IL-PDs than
in the main pancreatic duct (P < 0.05).
Phenotypic traits of cells within finer branches of the
pancreatic duct system
Beside PDGs, endodermal stem cell and progenitor cell
markers (Oct4a, Sox9, Pdx1, Lgr5, Ngn3) were investigated
in the finer branches of the pancreatic duct system (i.e.
intralobular and intercalated ducts). All were negative for
Oct4a (data not shown). Cells within intercalated (semi-
quantitative score = +++) but not in intralobular ducts
(semi-quantitative score = +/) were diffusely positive for
Sox9 (Fig. 3B). Sox9+ cells in intercalated ducts were also dif-
fusely positive for Pdx1 (semi-quantitative score = +++;
Fig. 6A,B) and Ngn3 (semi-quantitative score = ++; Fig. 6C,
D). Intercalated ducts were essentially negative for Lgr5
(data not shown). Accordingly, centro-acinar cells (the ter-
minal end duct cells interfacing with acini) were positive for
Sox9, Pdx1 and Ngn3 but negative for Lgr5 and Oct4.
Moreover, intercalated ducts were essentially negative
for insulin and glucagon (Fig. 6E). Nevertheless, intercalated
ducts were observed in direct continuity with clusters of
insulin+ cells organized in small pancreatic islet-like struc-
tures. In these cases, CK7+ duct cells were in direct continu-
ity with islets. Moreover, CK7+/insulin+ cells were present at
the interfaces between ducts and islets (Fig. 6E). Interca-
lated duct cells in continuity with endocrine islets had Sox9+
nuclei. Moreover, with transitioning from ducts to islets,
cells lost nuclear Sox9 positivity (Fig. 6F). Lgr5+ cells were
also present (two to three cells per islet) within pancreatic
islets, but Lgr5 positivity did not overlap with Sox9 and or
with insulin expression (Fig. 6G).
Discussion
The primary findings of the present study are: (1) the PDGs
in human pancreas are present only in the walls of larger
pancreatic ducts (diameter > 300 lm) and constitute  4%
of the duct wall area, irrespective of the duct size; (2) PDGs
represent niches consisting of a heterogeneous population
of Sox9+ cells; (3) the phenotypic traits of Sox9+ cells within
adult PDGs are consistent with those of pancreatic commit-
ted progenitor cells; (4) insulin+ cells are located also within
human PDGs but there was no overlap in expression of insu-
lin and various progenitor markers.
A large body of literature supports the currently accepted
interpretation that the postnatal pancreas contains commit-
ted progenitors, but not stem cells (Zhou et al. 2007; Xu
et al. 2008; Strobel et al. 2010; Smukler et al. 2011; Lysy
et al. 2012; Seifert & Xiong, 2014; Razavi et al. 2015; Yam-
aguchi et al. 2015). Although OCT4 and SOX2, classic
pluripotency genes, were found in rare cells in the postnatal
pancreas, their expression was found to be cytoplasmic, not
nuclear (Smukler et al. 2011). Subsequent studies revealed
Fig. 4 Expression of progenitor cell markers in pancreatic duct glands (PDGs). (A) Immunohistochemistry for Pdx1 in human pancreas. PDG cells
were diffusely positive for Pdx1 (arrows). (B) Double immunofluorescence for Pdx1 (red) and Sox9 (green); the nuclei are displayed in blue. Pdx1
co-localized with Sox9 in the same PDG cells (white nuclei, white arrows). (C) Immunofluorescence for Ngn3. Nuclei are displayed in blue. Ngn3+
cells were more numerous in PDGs associated with large interlobular ducts (arrows in right image) in comparison with the main pancreatic duct
(left image). (D) Double immunofluorescence for Lgr5 and Sox9 (left) or insulin (right); the nuclei are displayed in blue. Left image: Lgr5+ cells co-
expressed Sox9 (arrow). Right image: Lgr5+ cells (red arrows) were negative for insulin (green arrow).
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that the expression of these two pluripotency genes and
other key stem cell markers (e.g. NANOG) shifted from
nuclear to cytoplasmic or disappeared altogether with a
shift from the PBGs in the hepato-pancreatic common duct
to the neighbouring PDGs (Wang et al. 2013).
PDGs represent a unique compartment residing within
the pancreatic duct wall. A previous paper by Thayer and
associates showed that PDG intraductular pouches are more
frequent in proximal ducts than peripheral ducts and that
the distribution of these pouches is not uniform (Strobel
et al. 2010). In the present manuscript, we further investi-
gated the distribution of PDGs in the human pancreatic
duct system on the basis of duct type and size. Our data
indicate that PDGs are present in the main and larger inter-
lobular pancreatic ducts. Interestingly, interlobular pancre-
atic ducts with a diameter < 300 lm do not display PDGs
within their walls. Moreover, our results indicated that the
PDGs consistently constituted nearly 4% of the wall of each
duct examined. However, in agreement with the study of
Thayer and associates (Strobel et al. 2010), the presence of
PDGs correlated with the duct diameter. They were found
to be more numerous in the main pancreatic duct at the
head of the pancreas and progressively decreased with pro-
gression towards the tail and in larger interlobular ducts.
Finally, they disappeared in interlobular ducts with a diame-
ter < 300 lm.
From an anatomical point of view, PDGs represent the
pancreatic counterparts of PBGs within the biliary tree. Both
PDGs and PBGs are tubulo-alveolar glands composed of
mucinous (acid and neutral mucins) and serous acini. The
anatomical distribution of PDGs parallels that of PBGs
within the intrahepatic biliary tree, where glands are only
present in large bile ducts and their mass correlates with
duct size (Carpino et al. 2012).
The study by Thayer and associates indicated that PDGs
are composed mostly of mucin-producing cells (Strobel
et al. 2010). However, our previous paper (Wang et al.
2013) and the present study provide further information
regarding the progenitor cells within the human pancreatic
duct system. In the present manuscript, we further charac-
terized these niches and, in particular, showed that:
• PDGs represent novel anatomical niches of Sox9+ and
Lgr5+ progenitor cells in the adult human pancreas.
• The cells in the PDG niches exhibit a pattern of pheno-
typic traits implying a radial maturational lineage axis
of the progenitor cells.
• The proximal-to-distal maturational lineage axis starts
with the PBGs in the hepato-pancreatic common duct,
transitions to the main pancreatic duct and then to
the interlobular pancreatic duct.
Our data indicate that PDGs represent a novel anatomical
niche of [Oct4A/Sox9+] and Lgr5+ cells in the adult human
pancreas. In the development of the pancreas, the expres-
sion of Sox9 is essential for the maintenance of the pancre-
atic progenitor cell pool and has a key role in controlling
the bi-potential (ductal and endocrine) progenitor cell pop-
ulation (Seymour et al. 2008; Furuyama et al. 2011; Sey-
mour, 2014). Furthermore, in its commitment to the
endocrine pancreas, Sox9 expression within the primitive
epithelium is required for the induction of Ngn3, an indis-
pensable gene for endocrine differentiation (Seymour et al.
2008; Shih et al. 2012; Seymour, 2014). Interestingly, Sox9+
PDG cells co-expressed Pdx1 but not Oct4A, indicating a
committed progenitor rather than stem cell phenotype, an
interpretation corroborating prior findings by us (Wang
et al. 2013) and others (Zhou et al. 2007; Seifert & Xiong,
2014). A restricted Sox9+ sub-population also expressed
Fig. 5 Expression of pancreatic endocrine
markers in pancreatic duct glands (PDGs). (A)
Immunohistochemistry for insulin in human
pancreas. PDG cells were positive for insulin
(arrow in the right image). Area in the box is
magnified in the right image. Insulin+
pancreatic islets were present (arrowheads)
and represented the positive control. (B)
Double immunofluorescence for insulin
(green) and cytokeratin7 (CK7: red); the
nuclei are displayed in blue. Insulin+ cells
within PDGs are CK7+ (arrow). (C,D) Double
immunofluorescence for insulin (green) and
glucagon (red); the nuclei are displayed in
blue. Glucagon+ cells were present within
PDGs (magnified in D: arrow). Insulin+ and
glucagon+ pancreatic islet cells were present
(magnified in D) and represented positive
controls. Acinar cells and intercalated ducts
were essentially negative for insulin and
glucagon.
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Ngn3, indicating features associated with the endocrine
specification (Gomez et al. 2015). These observations indi-
cate that PDGs represent the niche of a heterogeneous pop-
ulation of committed progenitor cells.
In the present manuscript, we investigated the expression
of Lgr5 within adult human pancreata. Lgr5 is a marker in
multiple organs of adult stem cells and progenitors of
extensive proliferative potential (Clevers, 2013). In rodents,
Lgr5 expression can be induced in regenerating pancreatic
ducts by partial duct ligation (Huch et al. 2013; Dorrell et al.
2014). In these experimental conditions, Lgr5+ cells can be
isolated from pancreatic ducts and cultured into pancreatic
organoids; clonal pancreatic organoids can be induced to
differentiate into duct as well as endocrine cells upon trans-
plantation, thus proving their bi-potentiality (Huch et al.
2013). However, the fact that Oct4A was not expressed by
these Lgr5+ cells and that prior studies (Zhou et al. 2007;
Wang et al. 2013; Seifert & Xiong, 2014) found no evidence
of stem cells, implicate these as bipotent, committed pro-
genitors. Our results indicate that Lgr5 is expressed in nor-
mal adult human pancreas, but its expression is limited to a
restricted sub-population of Sox9+ and insulin/glucagon-
negative progenitors found at the bottoms of PDGs within
the duct walls. This sub-population could represent a more
primitive cell compartment within the pancreas, potentially
being intermediates (possibly transit amplifying cells?) that
are highly proliferative.
Interestingly, Lgr5+ cells were found within pancreatic
islets, but these cells were negative for Sox9 and endocrine
markers. Thus, it is likely that Lgr5 expression implies the
proliferative potential of the cells. Further studies are
required to elucidate the relevance of Lgr5 expression.
Fig. 6 Expression of progenitor cell markers in intercalated ducts. (A) Immunohistochemistry for Pdx1 and double immunofluorescence for Pdx1
and cytokeratin(CK)7. Intercalated ducts were diffusely Pdx1+ (arrows). (B) Double immunofluorescence for Pdx1 and Sox9 showed that Pdx1
mostly co-localized with Sox9 in intercalated duct cells (white nuclei in the merged image: arrows). (C) Immunohistochemistry for Ngn3 and double
immunofluorescence for Ngn3 and CK7. Numerous intercalated duct cells were Ngn3+ (arrows). (D) Double immunofluorescence for Ngn3 and
Sox9 showed that Ngn3 mostly co-localized with Sox9 in intercalated duct cells (white nuclei in the merged image: arrows). (E) Double immunoflu-
orescence for insulin and CK7. Some intercalated ducts appeared in continuity with clusters of insulin+ cells organized in small pancreatic islet-like
structures; in these cases, CK7+ duct cells were in direct continuity with islets. Moreover, CK7+/insulin+ cells were present at the interface between
duct and islet (arrows). (F) Double immunofluorescence for Sox9 and Lgr5. Intercalated duct cells in continuity with endocrine islets had Sox9+
nuclei (red arrows); moreover, transitioning from duct to islet, cells lost nuclear Sox9 positivity. Lgr5+ cells were also present (two to three cells per
islet) within pancreatic islets. Within the islets, Sox9 positivity did not overlap with Lgr5 expression (green arrows). (G) Double immunofluorescence
for insulin and Lgr5; within the islets, Lgr5 positivity (red arrows) did not overlap with insulin expression (green arrows). In immunoflurescence
images, nuclei are displayed in blue.
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Moreover, we showed that [Oct4A/Sox9+/Pdx1+] cells,
cells that are also PCNA+, were located primarily at the bot-
tom of PDGs; by contrast, the cells at the surface epithelium
were devoid of progenitor traits and were negative for
PCNA. This suggests a radial-axis maturational lineage, par-
alleling that found within the biliary tree. The presumptive
radial axis starts with early-stage proliferative progenitor
cells at the bottom of PDGs, found deep within duct walls,
and ends at the duct lumens with non-proliferative cells
devoid of progenitor cell traits. These features support the
concept that PDGs and their Sox9+ progenitor cell niches
have a role in the renewal of the pancreatic duct epithelium
(Yamaguchi et al. 2015).
Furthermore, we investigated the distribution within
PDGs of key transcription factors implicated in the develop-
ment of exocrine and endocrine pancreas. In our prior stud-
ies (Wang et al. 2013), we evaluated Pdx1 and Ngn3
expression in PDGs but without considering the location of
the particular PDG within the pancreatic duct system. In the
present manuscript, we evaluated the PDG phenotypic traits
and correlated the traits with respect to their location. In
particular, their distribution has been separately evaluated
in PDGs associated with the main and interlobular pancre-
atic ducts. Interestingly, in the main pancreatic duct, the
Sox9+ PDG cells were [Oct4A/Pdx1+/Ngn3]; interestingly,
in the interlobular pancreatic ducts, Ngn-3+ PDG cells were
more numerous than in the main pancreatic duct. Consis-
tent with their potential to move towards an endocrine
fate, a sub-population of PDG cells expressed pancreatic
endocrine hormones such as insulin and glucagon. Insulin-
(or glucagon) positive cells were more numerous in the
interlobular duct than in the main pancreatic duct.
Our findings here complete our studies regarding the
anatomical organization of niches of endodermal stem/pro-
genitor cells and support the concept of a radial axis of a
maturational lineage of stem cells and progenitors within
the biliary tree and a parallel one of committed progenitors
within the pancreas (Cardinale et al. 2011, 2012a; Carpino
et al. 2012; Wang et al. 2013).
In adults, a proximal-to-distal maturational lineage axis is
present starting with an abundance of stem cells in PBGs in
the hepato-pancreatic common duct near to the duode-
num, transitioning to committed progenitors and then to
mature cells with progression along the biliary tree into the
liver or into the pancreas (Cardinale et al. 2011, 2012a; Car-
pino et al. 2012; Wang et al. 2013). Here, we further
demonstrated that, transitioning from the main pancreatic
duct to the interlobular ducts, the PDGs modify their
immunophenotype and reduce mucin production. A distinc-
tion between liver and pancreas is that cells retaining stem
cell traits are present intrahepatically, whereas all cells
within the pancreas are devoid of stem cell traits but retain
properties indicative of committed progenitors (Zhou et al.
2007; Wang et al. 2013; Seifert & Xiong, 2014). The reason
(s) for this distinction is not yet known.
Our results further indicate that the in situ PDG niche con-
tains insulin- and glucagon-producing cells. However, the
response of the PDG niche to hyperglycaemic conditions,
and their role in generating insulin-producing cells in
pathological conditions (e.g. diabetes) should be further
evaluated.
In adult pancreas, another Sox9+ cell niche, besides that
in the PDGs, is located throughout the epithelium of inter-
calated ducts, including the centro-acinar cells (Reichert &
Rustgi, 2011; Kawaguchi, 2013). The potential of this niche
to participate in the turnover of endocrine islets has been
at the centre of a long-standing debate (Inada et al. 2008;
Xu et al. 2008; Criscimanna et al. 2011; Furuyama et al.
2011; Kopp et al. 2011a,b; Hosokawa et al. 2015). Divergent
studies have indicated the possibility that a subpopulation
of Sox9+ cells can give rise to islet cells in the adult rodents,
but this activation requires some form of injury (Crisci-
manna et al. 2011). In the present report, we demonstrated
the expression of Pdx1 and Ngn3 by Sox9+ cells within
human intercalated ducts. Our data on Sox9 expression in
intercalated duct cells are consistent with the evidence in
rodent pancreas (Seymour et al. 2007; Hosokawa et al.
2015) and human pancreas (Tanaka et al. 2013; Seymour,
2014). Actually, in the present study, the percentage of
Sox9+ cells within intercalated ducts is slightly lower in com-
parison with that in the study of Tanaka et al. (2013). How-
ever, samples from Tanaka et al.’s study came from patients
who underwent distal pancreatectomy for gastric cancer. In
contrast, our samples were obtained from organs discarded
during transplantation procedures, and we ruled out the
presence of underlying biliary or pancreatic disorders.
Therefore, the higher numbers of Sox9+ cells in the studies
by Tanaka et al. (2013) could represent a cellular reaction
to the pathological involvement of the pancreas which
made the resection necessary.
Several lines of evidence in rodents have indicated that
Pdx1 and Ngn3 are expressed in pancreatic ductal cells dur-
ing embryological development but are restricted to islets
in adult mice (Seymour et al. 2007; Wang et al. 2009; Sey-
mour, 2014); however, in adult mouse pancreas, Ngn3
expression has been seen in ductal cells during islet regener-
ation after different types of injury (Xu et al. 2008; Collom-
bat et al. 2009). Interestingly, our data in humans indicated
that these transcription factors are expressed by interca-
lated duct cell in adults. Our observations are in accordance
with other studies (Kobayashi et al. 2014; Gomez et al.
2015) and confirm the presence of endocrine features in
ductal cells in adult human pancreas. Ductal Sox9+ cells are
occasionally found in strict continuity with pancreatic islets,
as reported elsewhere (Zhao et al. 2008). Moreover, cells
with an intermediate phenotype (ductal/endocrine: CK7+/in-
sulin+ can be found at the interface between ducts and
islets. Furthermore, the progressive loss of Sox9 nuclear
expression was observed moving from duct to islet. These
observations suggest a transition from duct to islet and a
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possible relationship between Sox9+ intercalated duct cells
and pancreatic islet cells in adult humans. In general, our
results seem to further underscore the heterogeneity
between rodents and humans regarding spatial localization
of pancreatic islets which is characterized by the prevalence
of intralobularly located, peripheral duct islets in humans
(Merkwitz et al. 2013).
In summary, a major point of this manuscript is the
description in adult human pancreas of two distinct niches
of Sox9+ (progenitor) cells with different immunopheno-
types. Interestingly, no marker exists to precisely label and
isolate putative progenitor cells within the pancreas. There-
fore, a detailed immunophenotyping and a constellation of
markers are necessary to characterize these cells and their
anatomical location. In this context, our results indicated
that Sox9+ cells are not restricted to intercalated or interlob-
ular duct epithelium but are present also in PDGs; more-
over, Sox9+/Lgr5+ cells are restricted to PDGs, whereas duct
epithelium is almost negative for Lgr5. Finally, Lgr5+ cells
within pancreatic islets are Sox9–.
Our results have important anatomic and patho-physiolo-
gic implications. The present manuscript clearly indicates
the similarities between the pancreatic duct system and the
intrahepatic biliary tree. Interestingly, both the pancreatic
duct system and the intrahepatic and extrahepatic biliary
tree are anatomically heterogeneous. The heterogeneity in
the biliary tree also includes the physiological and prolifera-
tive capabilities of cholangiocytes lining larger or smaller
ducts (Glaser et al. 2009) and has profound implications in
biliary disorders (Carpino et al. 2015).
Also, the biliary tract and the pancreas are affected by a
number of pathologies showing significant clinico-patholo-
gic similarities; some of these pathologies affect the two
organs simultaneously. Typical examples are:
• The IgG4-related disease that affects, in the same
patient, the biliary tract, such as IgG4-related scleros-
ing cholangitis, and the pancreas, such as lympho-plas-
matic sclerosing autoimmune pancreatitis (Okazaki
et al. 2014).
• Pure mucin-secreting cholangiocarcinoma (CCA) show-
ing extensive similarities with ductal pancreatic adeno-
carcinoma.
• Preneoplastic lesions of bile ducts and pancreatic ducts
(Nakanuma et al. 2014).
Neoplastic diseases of bile ducts and pancreatic ducts
merit further discussion. CCA and ductal pancreatic adeno-
carcinoma share similar pathologic features and genetic
abnormalities (Nakanuma & Sato, 2014; Sato et al. 2014).
PBGs have been proposed as the site of origin of CCA (Car-
dinale et al. 2012b; Igarashi et al. 2013), but our results also
suggest that PDGs are candidate sites of origin of pancreatic
intra-epithelial neoplasias (PanIN) and pancreatic duct ade-
nocarcinomas. Also, in response to injury, PDGs undergo a
mucinous metaplasia with PanIN features (Strobel et al.
2010). Furthermore, BrdU incorporation and production of
pancreatic cancer-specific proteins in PDGs are increased in
the course of experimental diabetes and chronic pancreati-
tis (Bobrowski et al. 2013). Moreover, the development of
PanIN lesions in vivo may involve the emergence of a stem/
progenitor-like population that expresses Sox9 and Pdx1
(Kopp et al. 2012; Delgiorno et al. 2014). Our results are
consistent with this scenario. PDGs, in fact, contain Sox9+/
Pdx1+ progenitor cells and mucin-producing cells, and their
anatomical distribution overlaps with sites at which pancre-
atic adenocarcinoma occurs.
Concluding remarks
The present manuscript further underscores the anatomical
similarity between the biliary tree and pancreatic duct sys-
tem. This link derives from a common embryologic origin
and could have important implications in the patho-physiol-
ogy of the biliary tract and the pancreas.
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